ICON Shares Outstanding 2010-2025 | ICLR

ICON shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ICON shares outstanding for the quarter ending March 31, 2025 were 0.081B, a 2.79% decline year-over-year.
  • ICON 2024 shares outstanding were 0.083B, a 0.38% increase from 2023.
  • ICON 2023 shares outstanding were 0.083B, a 0.3% increase from 2022.
  • ICON 2022 shares outstanding were 0.082B, a 21.16% increase from 2021.
ICON Annual Shares Outstanding
(Millions of Shares)
2024 83
2023 83
2022 82
2021 68
2020 53
2019 54
2018 55
2017 55
2016 56
2015 60
2014 63
2013 62
2012 60
2011 61
2010 61
2009 60
ICON Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 81
2024-12-31 83
2024-09-30 83
2024-06-30 83
2024-03-31 83
2023-12-31 83
2023-09-30 83
2023-06-30 83
2023-03-31 83
2022-12-31 82
2022-09-30 82
2022-06-30 82
2022-03-31 83
2021-12-31 68
2021-09-30 81
2021-06-30 53
2021-03-31 53
2020-12-31 53
2020-09-30 53
2020-06-30 53
2020-03-31 54
2019-12-31 54
2019-09-30 55
2019-06-30 54
2019-03-31 54
2018-12-31 55
2018-09-30 55
2018-06-30 55
2018-03-31 55
2017-12-31 55
2017-09-30 55
2017-06-30 55
2017-03-31 55
2016-12-31 56
2016-09-30 57
2016-06-30 57
2016-03-31 56
2015-12-31 60
2015-09-30 60
2015-06-30 62
2015-03-31 62
2014-12-31 62
2014-09-30 63
2014-06-30 63
2014-03-31 63
2013-12-31 63
2013-09-30 62
2013-06-30 62
2013-03-31 61
2012-12-31 61
2012-09-30 60
2012-06-30 61
2012-03-31 61
2011-12-31 61
2011-09-30 61
2011-06-30 61
2011-03-31 61
2010-12-31 61
2010-09-30 61
2010-06-30 61
2010-03-31 60
2009-12-31 60
2009-09-30 60
2009-06-30 60
2009-03-31 60
Sector Industry Market Cap Revenue
Medical Medical Services $10.255B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.174B 25.17
Elevance Health (ELV) United States $86.874B 11.21
CVS Health (CVS) United States $76.179B 9.47
Cencora (COR) United States $56.230B 19.56
DiDi Global (DIDIY) China $23.297B 35.36
Natera (NTRA) United States $20.821B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.571B 13.31
EUROFINS SCIENT (ERFSF) Luxembourg $12.522B 0.00
CochLear (CHEOY) Australia $11.391B 0.00
Revvity (RVTY) United States $10.665B 18.35
Viatris (VTRS) United States $9.976B 3.43
Doximity (DOCS) United States $9.570B 44.57
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.657B 42.59
Medpace Holdings (MEDP) United States $8.422B 22.37
Sonic Healthcare (SKHHY) Australia $8.157B 0.00
Charles River Laboratories (CRL) United States $6.660B 13.05
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $3.994B 36.97
Bausch + Lomb (BLCO) Canada $3.976B 23.44
Sotera Health (SHC) United States $3.480B 19.77
Surgery Partners (SGRY) United States $2.896B 37.67
Alignment Healthcare (ALHC) United States $2.867B 0.00
Concentras Parent (CON) United States $2.744B 15.86
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.117B 9.02
GeneDx Holdings (WGS) United States $1.921B 73.99
Premier (PINC) United States $1.910B 14.50
Progyny (PGNY) United States $1.791B 39.42
PACS (PACS) United States $1.494B 0.00
GoodRx Holdings (GDRX) United States $1.364B 27.29
Teladoc Health (TDOC) United States $1.211B 0.00
Pediatrix Medical (MD) United States $1.200B 9.13
Establishment Labs Holdings (ESTA) $1.066B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.953B 14.88
Agilon Health (AGL) United States $0.911B 0.00
Nutex Health (NUTX) United States $0.901B 13.61
AMN Healthcare Services Inc (AMN) United States $0.830B 7.77
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.614B 4.14
InnovAge Holding (INNV) United States $0.543B 0.00
LifeMD (LFMD) United States $0.523B 0.00
Enhabit (EHAB) United States $0.520B 42.75
Auna S.A (AUNA) Luxembourg $0.505B 11.37
Sonida Senior Living (SNDA) United States $0.465B 0.00
SBC Medicals (SBC) United States $0.398B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.388B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.214B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.098B 0.00
So-Young (SY) China $0.088B 0.00
Sera Prognostics (SERA) United States $0.071B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.052B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00